Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-04T00:41:18.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    An NIH-wide announcement about terminology and website updates appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:43:38.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:43:41.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the expected study details with an access-block message.
    Difference
    18%
    Check dated 2026-09-23T00:52:56.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The revision line on the page updates from v3.6.6 to v3.7.0, indicating a routine page revision rather than a change to study information or layout.
    Difference
    0.1%
    Check dated 2026-09-16T00:09:25.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.5 to v3.6.6, indicating a newer version of the ClinicalTrials.gov entry. This appears to be a metadata update rather than a change to study details or visible content.
    Difference
    0.1%
    Check dated 2026-09-01T19:30:21.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.